Osteoblasts induce Ca2+ oscillation-independent NFATc1 activation during osteoclastogenesis (Proceedings of the National Academy of Sciences of the United States of America (2008) 105, 25, (8643-8648) DOI:10.1073/pnas.0800642105);Osteoblasts induce Ca2+ oscillation-independent NFATc1 activation during osteoclastogenesis

Proceedings of the National Academy of Sciences of the United States of America

Volumn 105, Issue 25, 2008, Pages 8643-8648

  Kuroda, Yukiko ^a,b   Hisatsune, Chihiro ^a,b,c   Nakamura, Takeshi ^c   Matsuo, Koichi ^d   Mikoshiba, Katsuhiko ^a,d  

^a UNIVERSITY OF TOKYO   (Japan)

^b RIKEN BRAIN SCIENCE INSTITUTE   (Japan)

^c JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

^d KEIO UNIVERSITY   (Japan)

Author keywords

Calcium; Differentiation; Inositol 1,4,5 trisphosphate receptor (IP3R); Osteoclast; Receptor activator of NF B ligand (RANKL)

Indexed keywords

CALCINEURIN; CALCIUM ION; COLONY STIMULATING FACTOR 1; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INOSITOL 1,4,5 TRISPHOSPHATE RECEPTOR; TACROLIMUS; TRANSCRIPTION FACTOR NFAT; CALCIUM; OSTEOCLAST DIFFERENTIATION FACTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BONE MARROW CELL; CELL DIFFERENTIATION; COCULTURE; CONTROLLED STUDY; IN VIVO STUDY; MACROPHAGE; MOUSE; NONHUMAN; OSCILLATION; OSTEOBLAST; PRIORITY JOURNAL; ANIMAL; BIOLOGICAL MODEL; CELL COMMUNICATION; METABOLISM; MOUSE MUTANT; OSTEOCLAST; SIGNAL TRANSDUCTION;

ANIMALS; CALCIUM; CELL COMMUNICATION; CELL DIFFERENTIATION; INOSITOL 1,4,5-TRISPHOSPHATE RECEPTORS; MICE; MICE, KNOCKOUT; MODELS, BIOLOGICAL; NF-KAPPA B; NFATC TRANSCRIPTION FACTORS; OSTEOBLASTS; OSTEOCLASTS; RANK LIGAND; SIGNAL TRANSDUCTION;

EID: 47249151777     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.0805906105     Document Type: Erratum

References (37)

1. Boyle WJ, Simonet WS, Lacey DL (2003) Osteoclast differentiation and activation. Nature 423:337-342.
2. Karsenty G, Wagner EF (2002) Reaching a genetic and molecular understanding of skeletal development. Dev Cell 2:389-406.
3. Yasuda H, et al. (1998) Osteoclast differentiation factor is a ligand for osteoprotegerin/ osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL. Proc Natl Acad Sci USA 95:3597-3602.
4. Lacey DL, et al. (1998) Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation. Cell 93:165-176.
5. Kong YY, et al. (1999) OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis. Nature 397:315-323.
6. Hsu H, et al. (1999) Tumor necrosis factor receptor family member RANK mediates osteoclast differentiation and activation induced by osteoprotegerin ligand. Proc Natl Acad Sci USA 96:3540-3545.
7. Yoshida H, et al. (1990) The murine mutation osteopetrosis is in the coding region of the macrophage colony stimulating factor gene. Nature 345:442-444.
8. Lagasse E, Weissman IL (1997) Enforced expression of BcI-2 in monocytes rescues macrophages and partially reverses osteopetrosis in op/op mice. Cell 89:1021-1031.
9. Naito A, et al. (1999) Severe osteopetrosis, defective interleukin-1 signalling and lymph node organogenesis in TRAF6-deficient mice. Genes Cells 4:353-362.
10. Wong BR, et al. (1998) The TRAF family of signal transducers mediates NF-kappaB activation by the TRANCE receptor. J Biol Chem 273:28355-28359.
11. Kobayashi N, et al. (2001) Segregation of TRAF6-mediated signaling pathways clarifies its role in osteoclastogenesis. EMBO J 20:1271-1280.
12. Matsuo K, et al. (2000) Fosl 1 is a transcriptional target of c-Fos during osteoclast differentiation. Nat Genet 24:184-187.
13. Wagner EF, Karsenty G (2001) Genetic control of skeletal development. Curr Opin Genet Dev 11:527-532.
14. Takayanagi H, et al. (2002) Induction and activation of the transcription factor NFATc1 (NFAT2) integrate RANKL signaling in terminal differentiation of osteoclasts. Dev Cell 3:889-901.
15. Crabtree GR (1999) Generic signals and specific outcomes: signaling through Ca2+, calcineurin, and NF-AT. Cell 96:611-614.
16. Graef IA, Chen F, Crabtree GR (2001) NFAT signaling in vertebrate development. Curr Opin Genet Dev 11:505-512.
17. Rusnak F, Mertz P (2000) Calcineurin: Form and function. Physiol Rev 80:1483-1521.
18. Higo T, et al. (2005) Subtype-specific and ER lumenal environment-dependent regulation of inositol 1,4,5-trisphosphate receptor type 1 by ERp44. Cell 120:85-98.
19. Ando H, et al. (2006) IRBIT suppresses IP3 receptor activity by competing with IP3 for the common binding site on the IP3 receptor. Mol Cell 22:795-806.
20. Miyakawa T, et al. (1999) Encoding of Ca2+ signals by differential expression of IP3 receptor subtypes. EMBO J 18:1303-1308.
21. Hattori M, et al. (2004) Distinct roles of inositol 1,4,5-trisphosphate receptor types 1 and 3 in Ca2+ signaling. J Biol Chem 279:11967-11975.
22. Sugawara H, Kurosaki M, Takata M, Kurosaki T (1997) Genetic evidence for involvement of type 1, type 2 and type 3 inositol 1,4,5-trisphosphate receptors in signal transduction through the B-cell antigen receptor. EMBO J 16:3078-3088.
23. Groth RD, Mermelstein PG (2003) Brain-derived neurotrophic factor activation of NFAT (nuclear factor of activated T cells)-dependent transcription: A role for the transcription factor NFATc4 in neurotrophin-mediated gene expression. J Neurosci 23:8125-8134.
24. Matsumoto M, et al. (1996) Ataxia and epileptic seizures in mice lacking type 1 inositol 1,4,5-trisphosphate receptor. Nature 379:168-171.
25. Futatsugi A, et al. (2005) IP3 receptor types 2 and 3 mediate exocrine secretion underlying energy metabolism. Science 309:2232-2234.
26. Zhao C, et al. (2006) Bidirectional ephrinB2-EphB4 signaling controls bone homeostasis. Cell Metab 4:111-121.
27. Dolmetsch RE, Xu K, Lewis RS (1998) Calcium oscillations increase the efficiency and specificity of gene expression. Nature 392:933-936.
28. Koga T, et al. (2004) Costimulatory signals mediated by the ITAM motif cooperate with RANKL for bone homeostasis. Nature 428:758-763.
29. Rao A, Luo C, Hogan PG (1997) Transcription factors of the NFAT family: regulation and function. Annu Rev Immunol 15:707-747.
30. Gwack Y, et al. (2006) A genome-wide Drosophila RNAi screen identifies DYRK-family kinases as regulators of NFAT. Nature 441:646-650.
31. Arron JR, et al. (2006) NFATdysregulation by increased dosage of DSCR1 and DYRK1A on chromosome 21. Nature 441:595-600.
32. Cvetkovic M, et al. (1994) The deleterious effects of long-term cyclosporine A, cyclosporine G, and FK506 on bone mineral metabolism in vivo. Transplantation 57:1231-1237.
33. KogaT, et al. (2005) NFAT and Osterix cooperatively regulate bone formation. NatMed 11:880-885.
34. Lean JM, et al. (2000) Osteoclast lineage commitment of bone marrow precursors through expression of membrane-bound TRANCE. Bone 27:29-40.
35. Maeda N, Niinobe M, Nakahira K, Mikoshiba K (1988) Purification and characterization of P400 protein, a glycoprotein characteristic of Purkinjecell, from mouse cerebellum. J Neurochem 51:1724-1730.
36. Sugiyama T, et al. (1994) Monoclonal antibodies distinctively recognizing the subtypes of inositol 1,4,5-trisphosphate receptor: Application to the studies on inflammatory cells. FEBS.Lett 354:149-154.
37. Matsuo K, et al. (2004) Nuclear factor of activated T-cells (NFAT) rescues osteoclastogenesis in precursors lacking c-Fos. J Biol Chem 279:26475-26480.